L-asparaginase has been used as a key component of ALL treatment protocols for the past 50 years and is particularly effective in lymphoblastic leukaemia due to these cells typically lacking the enzyme asparagine synthetase (ASNS) [14]. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.